Search Within

Michael Morris

  1. "Jeremy Durack"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (13)
  3. Correspondence (1)
Groups
  1. Department of Medicine (28)
  2. Genitourinary Oncology Service (28)
  3. Solid Tumor Oncology Division (28)
  4. Radiology, Department of (21)
  5. GSK Faculty (18)
  6. Center for Pancreatic Cancer Research (17)

More Groups

People
  1. Jeremy Durack (28)
  2. Howard Scher (17)
  3. Stephen Solomon (16)
  4. Victor Reuter (12)
  5. Neeta Pandit-Taskar (10)
  6. Steven Larson (9)

More People

Years
  1. 2025 (1)
  2. 2022 (1)
  3. 2021 (5)
  4. 2020 (1)
  5. 2019 (2)
  6. 2018 (3)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Journal of Nuclear Medicine (4)
  3. Clinical Cancer Research (3)
  4. European Journal of Nuclear Medicine and Molecular Imaging (2)
  5. Journal of Urology (2)
  6. Cell (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. Society of Nuclear Medicine (4)
  3. American Association for Cancer Research (3)
  4. Elsevier Science, Inc. (2)
  5. Nature Publishing Group (2)
  6. Springer (2)

More Publishers

Results (28)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical, imaging, and technical factors associated with successful genomic profiling of bone biopsy tissue in prostate cancer
    Journal Article

    Ridouani, F.; Vargas, H. A.; Holzwanger, D. J.; Schòˆder, H.; Waters, E.; Petre, E. N.; Martin, A.; Satagopan, J.; Gonen, M.; Autio, K. A.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer
    Journal Article

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A prospective phase 2/3 study of PSMA-targeted (18)F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A sub-analysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging
    Meeting Abstract

    Durack, J. C.; Alva, A. S.; Preston, M. A.; Pouliot, F.; Saperstein, L.; Carroll, P. R.; Pienta, K. J.; Rowe, S. P.; Patnaik, A.; Probst, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase 2/3 prospective multicenter study of the diagnostic accuracy of prostate specific membrane antigen PET/CT with (18)F-DCFPyL in prostate cancer patients (OSPREY)
    Journal Article

    Pienta, K. J.; Gorin, M. A.; Rowe, S. P.; Carroll, P. R.; Pouliot, F.; Probst, S.; Saperstein, L.; Preston, M. A.; Alva, A. S.; Patnaik, A.; more...
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • Reply by authors
    Correspondence

    Pienta, K. J.; Gorin, M. A.; Rowe, S. P.; Carroll, P. R.; Pouliot, F.; Probst, S.; Saperstein, L.; Preston, M. A.; Alva, A. S.; Patnaik, A.; more...
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • A prospective phase II/III study of PSMA-targeted 18F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A subanalysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging
    Meeting Abstract

    Durack, J. C.; Alva, A. S.; Preston, M. A.; Pouliot, F.; Saperstein, L.; Carroll, P. R.; Pienta, K. J.; Rowe, S. P.; Patnaik, A.; Probst, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Immunomodulatory activity of a colony-stimulating factor-1 receptor inhibitor in patients with advanced refractory breast or prostate cancer: A phase I study
    Journal Article

    Autio, K. A.; Klebanoff, C. A.; Schaer, D.; Kauh, J. S. W.; Slovin, S. F.; Adamow, M.; Blinder, V. S.; Brahmachary, M.; Carlsen, M.; Comen, E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • (11)C-choline PET/CT in recurrent prostate cancer: Retrospective analysis in a large U.S. patient series
    Journal Article

    Michaud, L.; Touijer, K. A.; Mauguen, A.; Zelefsky, M. J.; Morris, M. J.; Lyashschenko, S. K.; Durack, J. C.; Humm, J. L.; Weber, W. A.; Schòˆder, H.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Diagnostic performance of (18)F-DCFPyL in the OSPREY Trial: A prospective phase 2/3 multicenter study of (18)F-DCFPyL PET/CT imaging in patients (Pts) with known or suspected metastatic prostate cancer (mPC)
    Meeting Abstract

    Morris, M. J.; Durack, J. C.; Alva, A. S.; Vargas, H. A.; Piert, M.; Pachynski, R. K.; Pouliot, F.; Beauregard, J. M.; Preston, M. A.; Choudhury, A. D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Results from the OSPREY trial: A Prospective phase 2/3 multi-center study of (18)F-DCFPyL PET/CT imaging in patients with prostate cancer: Examination of diagnostic accuracy
    Meeting Abstract

    Rowe, S.; Gorin, M.; Pienta, K.; Siegel, B.; Carroll, P.; Pouliot, F.; Probst, S.; Saperstein, L.; Preston, M.; Alva, A.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save